Step by step daily management of short-term mechanical circulatory support for cardiogenic shock in adults in the intensive cardiac care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology SC, the European Society of Intensive Care Medicine, the European branch of the Extracorporeal Life Support Organization, and the European Association for Cardio-Thoracic Surgery
- PMID: 37315190
- DOI: 10.1093/ehjacc/zuad064
Step by step daily management of short-term mechanical circulatory support for cardiogenic shock in adults in the intensive cardiac care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology SC, the European Society of Intensive Care Medicine, the European branch of the Extracorporeal Life Support Organization, and the European Association for Cardio-Thoracic Surgery
Abstract
The use of mechanical circulatory support using percutaneous ventricular assist devices (pVAD) has increased rapidly during the last decade without substantial new evidence for their effect on outcome. In addition, many gaps in knowledge still exist such as timing and duration of support, haemodynamic monitoring, management of complications, concomitant medical therapy, and weaning protocols. This clinical consensus statement summarizes the consensus of an expert panel of the Association for Acute CardioVascular Care, European Society of Intensive Care Medicine, European Extracorporeal Life Support Organization, and European Association for Cardio-Thoracic Surgery. It provides practical advice regarding the management of patients managed with pVAD in the intensive care unit based on existing evidence and consensus on best current practice.
Keywords: Association for Acute CardioVascular Care; Cardiogenic shock; European Association for Cardio-Thoracic Surgery; European Society of Intensive Care Medicine; Extracorporeal Life Support Organization; Mechanical circulatory support.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: J.E.M.: speaker honorarium from Abbott, Abiomed, Boehringer Ingelheim, and Orion. Institutional research grant: Abiomed, Novo Nordic Foundation, and Danish Heart Foundation; A.S.: no disclosures, N.A.: no disclosures, A.A.: no disclosures, J.B.: consultant for Getinge, Abiomed, and Xenios; D.B.: no disclosures, G.F.: no disclosures, C.G.T.: no disclosures, A.M.: has received grants from Roche Diagnostics, Abbott Laboratories, 4TEEN4, and Windtree Therapeutics; has received honoraria for lectures from Roche Diagnostics, Bayer, and MSD; and is a consultant for Corteria Pharmaceuticals, S-Form Pharma, FIRE-1, Implicity, 4TEEN4, and Adrenomed; S.P.: no disclosures, J.S.: no disclosures, H.T.: no disclosures, and C.H.: speaker honorarium from Abiomed.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
